Form EFFECT ONCOLYTICS BIOTECH INC
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | August 29, 2025 4:00 P.M. |
| Form: | F-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AP Memory Strengthens Global Leadership Team with Appointment of Former Qualcomm Vice President Jian Zhang
- Faraday Future Founder and Global CEO YT Jia Shares Weekly Investor Update: Renewed Nasdaq Compliance, “Built in USA” Upgrades Including the Launch of Universal Beyond-Line-of-Sight Teleoperation
- Sungrow Retains No.1 Position in 2025 S&P Global PV Inverter Shipments Rankings
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share